2.4K
Articles
96.3K
Citations
4.9
avg. Impact Factor
134
h-index

Most Cited Articles of Department of Oncology in 2016

TitleJournalYearCitations
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Autophagy20163.8K
Antiangiogenic therapy in oncology: current status and future directionsLancet, The2016507
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker studyThe Lancet Gastroenterology and Hepatology2016160
Increased global transcription activity as a mechanism of replication stress in cancerNature Communications2016150
Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcomeHistopathology2016138
Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environmentsCancer & Metabolism2016135
Metalloprotease SPRTN/DVC1 Orchestrates Replication-Coupled DNA-Protein Crosslink RepairMolecular Cell2016133
Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting CompoundsMolecular Cell2016133
Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapyJournal of Molecular Medicine2016129
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSJournal of Medical Genetics2016121
Interplay between Fanconi anemia and homologous recombination pathways in genome integrityEMBO Journal2016119
Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cellsOncogene2016109
Structural analysis of human KDM5B guides histone demethylase inhibitor developmentNature Chemical Biology2016102
Structural Basis of Metallo-β-Lactamase Inhibition by Captopril StereoisomersAntimicrobial Agents and Chemotherapy201698
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trialLancet Oncology, The201694
Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic NicheCancer Cell201692
TGF-β Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP/SMAD2 Nuclear TranslocationMolecular Cell201691
30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational studyLancet Oncology, The201688
Expression of Idh1 in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early GliomagenesisCancer Cell201687
The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancerNucleic Acids Research201682
An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor OlaparibTargeted Oncology201681
Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry CohortsBehavior Genetics201677
The tumour hypoxia induced non-coding transcriptomeMolecular Aspects of Medicine201676
Oncolytic viruses: finally deliveringBritish Journal of Cancer201676
The extreme capsule fiber complex in humans and macaque monkeys: a comparative diffusion MRI tractography studyBrain Structure and Function201671